RENUKA PILLAI D.O. NPI 1780634378

NPI Details

Renuka Pillai, D.O. is an emergency medicine in Berkeley Heights, NJ with 25 years of experience. The provider is an emergency physician focuses on the immediate decision making and action necessary to prevent death or any further disability both in the pre-hospital setting by directing emergency medical technicians and in the emergency department. The emergency physician provides immediate recognition, evaluation, care, stabilization and disposition of a generally diversified population of adult and pediatric patients in response to acute illness and injury. Renuka Pillai, D.O. NPI is 1780634378. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:2001

The provider's business location address is:

1 DIAMOND HILL RD
BERKELEY HEIGHTS, NJ
ZIP 07922-104
Phone: (908) 273-4300

The NPI 1780634378 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Bacterial urine culture (HCPCS:87088)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Bacterial colony count, urine (HCPCS:87086)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of drug or substance into vein (HCPCS:96374)
• Unclassified drugs (HCPCS:J3490)
• Emergency department visit for life threatening or functioning severity (HCPCS:99285)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Lipase (fat enzyme) level (HCPCS:83690)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Bacterial culture, any other source except urine, blood or stool, aerobic (HCPCS:87070)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)

The enumeration date for this NPI number is 5/12/2006 and was last updated on 2/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: